The current study found that CTRP9 levels are positively correlated with glucose metabolism parameters in healthy subjects and patients with T2DM (T2DM and T2DM+CAD groups), suggesting a compensatory increase in CTRP9 in insulin-resistant conditions; however, more studies are needed to prove this concept. This evidence concerns the gene C1QTNF9 and coronary artery disorder.